Axon Enterprise (NASDAQ:AXON) President Sells 16,775 Shares

by · The Markets Daily

Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) President Joshua Isner sold 16,775 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Joshua Isner also recently made the following trade(s):

  • On Friday, June 5th, Joshua Isner sold 13,000 shares of Axon Enterprise stock. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00.

Axon Enterprise Stock Down 2.2%

Axon Enterprise stock traded down $11.32 during mid-day trading on Wednesday, reaching $506.98. The stock had a trading volume of 1,042,743 shares, compared to its average volume of 1,051,964. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $792.16. The company has a 50-day moving average price of $565.59 and a two-hundred day moving average price of $484.77. The company has a market capitalization of $41.19 billion, a price-to-earnings ratio of 210.37, a PEG ratio of 9.20 and a beta of 1.39. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.12 EPS. On average, analysts expect that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Hedge funds have recently made changes to their positions in the company. Brighton Jones LLC bought a new stake in Axon Enterprise in the fourth quarter worth about $480,000. NewEdge Advisors LLC raised its holdings in shares of Axon Enterprise by 41.1% in the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after buying an additional 668 shares during the period. Empowered Funds LLC raised its holdings in shares of Axon Enterprise by 8.4% in the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after buying an additional 157 shares during the period. Woodline Partners LP lifted its stake in shares of Axon Enterprise by 40.6% during the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after acquiring an additional 2,003 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Axon Enterprise during the 2nd quarter worth approximately $284,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. The Goldman Sachs Group reissued a “buy” rating and set a $715.00 price target on shares of Axon Enterprise in a report on Thursday, August 6th. UBS Group raised their price objective on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday. Finally, Piper Sandler raised their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $730.92.

View Our Latest Analysis on AXON

Axon Enterprise Company Profile

(Get Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

See Also